quinoyl tripeptide-35은 임신 중 안전한가요?

Related ingredients

Frequently asked questions

quinoyl tripeptide-35은 임신 중 안전한가요?

No harmonised CLP reproductive classifications (no H360/H361) identified for quinoyl tripeptide-35; no SCCS or CIR safety assessment or peer‑reviewed reproductive/toxicology studies located. As a peptide-based cosmetic active, it is expected to have low systemic hazard and, with topical cosmetic use, negligible absorption under normal conditions.

quinoyl tripeptide-35은 모유 수유 중 안전한가요?

No data found indicating reproductive or lactation-related toxicity, nor evidence of mammary gland effects or transfer into milk. Topical peptide cosmetic actives typically have minimal systemic availability; no authoritative sources flag breastfeeding risk.

quinoyl tripeptide-35은 아기 피부에 안전한가요?

No infant-specific safety or absorption data located. Given peptide chemistry and topical route, adult dermal systemic exposure is expected to be negligible (adult e=0). However, because infant skin (0–3 yr) has higher surface-area-to-weight ratio and less mature barrier, exposure score increased by +1 to e=1 to reflect low but potentially measurable absorption; no evidence of infant-specific hazard or mechanism was found.

VeriMom은 quinoyl tripeptide-35을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 quinoyl tripeptide-35을 100/100 (알려진 위험 없음)로 평가합니다.

임신 중 quinoyl tripeptide-35 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.